Poly(ADP-ribose) polymerase inhibitors and acute renal failure

PARP as a Therapeutic Target

Volumn , Issue , 2002, Pages 149-168

  Chatterjee, Prabal Kumar ^a   Thiemermann, Christoph ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0011469551     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (86)

1. Berger, S. J., Sudar, D. C., and Berger N. A., Metabolic consequences of DNA damage: DNA damage induces alterations in glucose metabolism by activation of poly(ADP-ribose) polymerase, Biochem. Biophys. Res. Commun., 134, 227, 1986.
2. Berger, N. A., Poly(ADP-ribose) in the cellular response to DNA damage, Radiat. Res., 101, 4, 1985.
3. Szabó, C. and Dawson, V. L., Role of poly(ADP-ribose) synthetase in inflammation and ischemia-reperfusion, Trends Pharmocol. Sci., 19, 287, 1998.
4. Carson, D. A. et al., DNA strand breaks, NAD metabolism and programmed cell death, Exp. Cell Res., 164, 273, 1986.
5. Zhang, J. et al., Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity, Science, 263, 687, 1994.
6. Bowes, J., Piper, J., and Thiemermann, C., Inhibitors of the activity of poly(ADP-ribose) synthetase reduce the cell death caused by hydrogen peroxide in human cardiac myoblasts, Br. J. Pharmacol., 124, 1760, 1998.
7. Bowes, J. et al., Inhibitors of poly(ADP-ribose) synthetase protect rat cardiomyocytes against oxidant stress, Cardiovasc. Res., 41, 126, 1999.
8. Schraufstatter, I. U. et al., Oxidant injury of cells: DNA strand-breaks activate polyadenosine diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine dinucleotide, J. Clin. Invest., 77, 1312, 1986.
9. Yamamoto, K., Tsukidate, K., and Farber, J., Differing effects of the inhibitors of poly(ADP-ribose) polymerase on the course of oxidative cell injury in hepatocytes and fibroblasts, Biochem. Pharmacol., 46, 483, 1993.
10. Schraufstatter, I. U. et al., Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase, Proc. Natl. Acad. Sci. U.S.A., 83, 4908, 1986.
11. + depletion and cytotoxicity in isolated hepatocytes, Biochem. Pharmacol., 37, 3967, 1988.
12. Thiemermann, C. et al., Inhibition of the activity of poly(ADP-ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle, Proc. Natl. Acad. Sci. U.S.A., 94, 679, 1994.
13. Thies, R. L. and Autor, A. P., Reactive oxygen injury to cultured pulmonary artery endothelial cells: mediation by poly(ADP-ribose) polymerase activation causing NAD depletion and altered energy balance, Arch. Biochem. Biophys., 286, 353, 1991.
14. 2 but not apoptosis, Gastroenterology, 109, 472, 1995.
15. Kennedy, M., Szabó. C., and Salzman, A. L., Activation of polyADP ribosyl synthetase mediates cytotoxicity induced by peroxynitrite in human intestinal epithelial cells, Gastroenterology, 114, 510, 1998.
16. Chatterjee, P. K., Cuzzocrea, S., and Thiemermann, C., Inhibitors of poly(ADP-ribose) synthetase protect rat proximal tubular cells against hydrogen peroxide-mediated oxidant stress, Kidney Int., 56, 973, 1999.
17. 1 cells, Am. J. Physiol., 277, F428, 1999.
18. Thadani, R., Pascual, M., and Bonventre, J. V., Acute renal failure, N. Eng. J. Med. 334, 1448, 1996.
19. Star, R. A., Treatment of acute renal failure, Kidney Int., 54, 1817, 1998.
20. Spiegel, D. M. et al., Determinants of survival and recovery in acute renal failure patients dialysed in intensive-care units, Am. J. Nephrol., 11, 44, 1991.
21. Novis, B. K. et al., Association of preoperative risk factors with postoperative acute renal failure, Anesth. Analg., 778, 143, 1994.
22. Zaranado, G. et al., Acute renal failure in the patient undergoing cardiac operation, J. Thorac. Cardiovasc. Surg. 107, 1489, 1994.
23. Maher, E. R. et al., Prognosis of critically ill patients with acute renal failure: APACHE II score and other predictive factors, Q. J. Med., 72, 857, 1989.
24. McCarthy, J. T., Prognosis of patients with acute renal failure in the intensive care unit: a tail of two eras, Mayo Clinic Proc., 71, 117, 1996.
25. Paller, M. S., The cell biology of reperfusion injury in the kidney, J. Invest. Med., 42, 632, 1994.
26. McComs, P. R. and Roberts, B., Acute renal failure following resection of abdominal aortic aneurysm, Surg. Gynecol. Obstet. 148, 175, 1979.
27. Aronson, S. and Blumenthal, R., Perioperative renal dysfunction and cardiovascular anesthesia: concerns and controversies, J. Cardiothorac. Vasc. Anesth., 17, 117, 1998.
28. Weight, S. C., Bell, P. R., and Nicholson, M. L., Renal ischemia-reperfusion injury, Br. J. Surg., 83, 162, 1996.
29. Shoskes, D. A. and Halloran, P. F., Delayed graft function in renal transplantation: etiology, management and long-term significance, J. Urol., 155, 1831, 1996.
30. Lieberthal, W. and Levine, J. S., Mechanisms of apoptosis and its potential role in renal tubular epithelial cell injury, Am. J. Physiol., 271, F477, 1996.
31. Grace, P. A., Ischaemia-reperfusion injury, Br. J. Surg., 81, 637, 1994.
32. Kloner, R. A., Przyklenk, K., and Whittaker, P., Deleterious effects of oxygen radicals in ischemia/reperfusion. Resolved and unresolved issues. Circulation, 80, 1115, 1989.
33. Lieberthal, W., Biology of ischemic and toxic renal tubular injury: role of nitric oxide and the inflammatory response, Curr. Opin. Nephrol. Hypertens., 7, 289, 1998.
34. Nath, K. A. and Norby, S. M., Reactive oxygen species and acute renal failure, Am. J. Med., 109, 655, 2000.
35. 6-(1-iminoethyl) lysine, J. Pharmacol. Exp. Ther., 295, 417, 2000.
36. Kadkhodaee, M. et al., DNA fragmentation reduced by antioxidants following ischaemia- reperfusion in the isolated perfused rat kidney, Nephrology 4, 163, 1998.
37. Chatterjee, P. K. et al., Inhibitors of poly(ADP-ribose) synthetase reduce ischemiareperfusion injury in the anesthetized rat in vivo, FASEB J., 14, 641, 2000.
38. Chatterjee, P. K., et al., Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat, Kidney Int., 58, 658, 2000.
39. Sen, C. K. and Packer, L., Antioxidant and redox regulation of gene transcription, FASEB J., 10, 709, 1996.
40. Bowie, A. and O’Neill L. A., Oxidative stress and nuclear factor-κ B activation: a reassessment of the evidence in the light of recent discoveries, Biochem. Pharmacol., 59, 13, 2000.
41. Green, C. J. et al., Reduced susceptibility to lipid peroxidation in cold ischemic rabbit kidneys after addition of desferrioxamine, mannitol or uric acid to the flush solution, Cryobiology, 23, 358, 1986.
42. Green, C. J., et al., Desferrioxamine reduces susceptibility to lipid peroxidation in rabbit kidneys subjected to warm ischaemia and reperfusion, Comp. Biochem. Physiol. 85, 113, 1986.
43. 2-induced injury, Lens. Eye. Toxic. Res., 9, 385, 1992.
44. Pincemail, J. et al., Ischemia-reperfusion injury of rabbit kidney: comparative effects of desferrioxamine and N-acetylcysteine as antioxidants, Transplant. Proc., 32, 475, 2000.
45. Green, C. J. et al., Allopurinol inhibits lipid peroxidation in warm ischemic and reperfused rabbit kidneys, Free Radical Res. Commun., 6, 329, 1989.
46. Hestin, D. and Johns, E. J., The influence of allopurinol on kidney haemodynamic and excretory responses to renal ischaemia in anaesthetized rats, Br. J. Pharmacol., 128, 255, 1999.
47. Jolly, S. R. et al., Canine myocardial reperfusion injury. Its reduction by combined administration of superoxide dismutase and catalase, Circ. Res., 54, 277, 1984.
48. Baker, G. L., Corry R. J., and Autor, A. P., Oxygen free radical induced damage in kidneys subjected to warm ischemia and reperfusion. Protective effect of superoxide dismutase, Ann. Surg., 202, 628, 1985.
49. Kim S. Y., et al., Effects of radical scavengers and antioxidant on ischemic acute renal failure in rabbits, Renal Fail., 21, 1-11, 1999.
50. Paller, M. S., Hoidal, J. R., and Ferris, T. F., Oxygen free radicals in ischemic acute renal failure in the rat, J. Clin. Invest., 74, 1156, 1984.
51. Fridovich, I., Superoxide radical and superoxide dismutases, Annu. Rev. Biochem., 64, 97, 1995.
52. Patel, N. S. A. et al., The stable nitroxyl radical TEMPONE reduces renal dysfunction and injury mediated by oxidative stress in the rat kidney, Free Radical Med. Biol., In press.
53. Kone, B. C. and Baylis, C., Biosynthesis and homeostatic roles of nitric oxide in the normal kidney, Am. J. Physiol., 272, F561, 1997.
54. Kone, B. C., Nitric oxide in renal health and disease, Am. J. Kidney Dis., 30, 311, 1997.
55. Hill-Kapturczak, N. et al., Nitric oxide and nitric oxide synthase in the kidney: potential roles in normal renal function and in renal dysfunction, Endothelium, 3, 253, 1995.
56. Cook, H. T. and Cattell, V., Role of nitric oxide in immune-mediated diseases, Clin. Sci., 91, 375, 1996.
57. Chatterjee, P. K., Hawksworth, G. M., and McLay, J. S., Cytokine-stimulated nitric oxide production in human renal proximal tubule and its modulation by natriuretic peptides: a novel immunomodulatory mechanism? Exp. Nephrol., 7, 438, 1999.
58. Weight, S. C., Furness, P. N., and Nicholson, M. L., Nitric oxide generation is increased in experimental renal warm ischaemia-reperfusion injury, Br. J. Surg., 85, 1663, 1998.
59. Noiri, E. et al., in vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia, J. Clin. Invest., 97, 2377, 1996.
60. Peresleni, T. et al., Antisense oligodeoxynucleotides to inducible NO synthase rescue epithelial cells from oxidative stress injury, Am. J. Physiol., 270, F971, 1996.
61. Ling, H. et al., Attenuation of renal ischemia-reperfusion injury in inducible nitric oxide synthase knockout mice, Am. J. Physiol., 277, F383, 1999.
62. Radi, R. et al., Unraveling peroxynitrite formation in biological systems, Free Radical Biol. Med., 30, 463, 2001.
63. Beckman, J. S., Oxidative damage and tyrosine nitration from peroxynitrite, Chem. Res. Toxicol., 9, 836, 1996.
64. Szabó, C. et al., DNA strand breakage, activation of poly-ADP ribosyl synthetase, and cellular energy depletion are involved in the cytotoxicity in macrophages and smooth muscle cells exposed to peroxynitrite, Proc. Natl. Acad. Sci. U.S.A., 93, 1753, 1996
65. Szabó, C. et al., Peroxynitrite causes energy depletion and increases permeability via activation of poly(ADP-ribose) synthetase in pulmonary epithelial cells, Am. J. Resp. Cell Mol. Biol., 16, 105, 1997.
66. Zingarelli, B. et al., Protection against myocardial ischemia and reperfusion by 3- aminobenzamide, an inhibitor of poly(ADP-ribose) synthetase, Cardiovasc. Res., 36, 205, 1997.
67. Bowes, J. et al., Reduction of myocardial reperfusion injury by an inhibitor of poly(ADP-ribose) synthetase in the pig, Eur. J. Pharmacol., 359, 143, 1998.
68. Eliasson, M. J. et al., Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia, Nat. Med., 3, 1089, 1997.
69. Endres, M. et al., Ischemic brain injury is mediated by the activation of poly(ADP-ribose) polymerase, J. Cereb. Blood Flow Metab., 17, 1143, 1997.
70. Cuzzocrea, S. et al., Beneficial effects of 3-aminobenzamide, an inhibitor of poly(ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion, Br. J. Pharmacol., 121, 1065, 1997.
71. Zingarelli, B., Salzman, A. L., and Szabó, C., Genetic disruption of poly(ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury, Circ. Res., 83, 85, 1998.
72. Liaudet, L. et al., Poly(ADP-ribose) synthetase mediates intestinal mucosal barrier dysfunction after mesenteric ischemia, Shock, 14, 134, 2000.
73. Vamvakas, S., Richter, H., and Bittner, D., Poly(ADP-ribosyl)ation and nuclear matrix/intermediate filament proteins in renal carcinogenesis, Rec. Res. Cancer. Res., 143, 195, 1997.
74. Schnellmann, R. G., Swagler, A. R., and Compton, M. M., Absence of endonuclease activation during acute cell death in renal proximal tubules, Am. J. Physiol., 265, C485, 1993.
75. Schneeweiss, F. H. A. et al., A strong static magnetic field inhibits the poly-ADP-ribosylation of proteins in human kidney T1-cells, Bioelectrochem. Bioenerg., 30, 111, 1993.
76. Banasik, M. and Ueda, K., Dual inhibitory effects of dimethyl sulfoxide on poly(ADP-ribose) synthetase, J. Enz. Inhib., 14, 239, 1999.
77. Jung, J. S. et al., Protection against hydrogen peroxide induced injury in renal proximal tubule cell lines by inhibition of poly(ADP-ribose) synthase, Kidney Blood Pressure Res., 23, 14, 2000.
78. Min S. K. et al., Role of lipid peroxidation and poly(ADP-ribose) polymerase activation in oxidant-induced membrane transport dysfunction in opossum kidney cells, Toxicol. Appl. Pharmacol., 166, 196, 2000.
79. Dierenfeldt, S. M., Warnick, T., and Lazarus, H. M., in vivo ischemia and storage injury cause alterations in the activity of poly(adenosine diphosphate ribose)synthetase, Biochem. Med. Metab. Biol., 38, 88, 1987.
80. Martin, D. R. et al., Inhibition of poly(ADP-ribose) polymerase attenuates ischemic renal injury in rats, Am. J. Physiol., 279, R1834, 2000.
81. Bonventre, J. V., Mechanisms of ischemic acute renal failure, Kidney Int., 43, 1160, 1993.
82. Alkhunaizi, A. M. and Schrier, R. W., Management of acute renal failure: new perspectives, Am. J. Kidney Dis., 28, 315, 1996.
83. Edelstein, C. L. et al., Emerging therapies for acute renal failure, Am. J. Kidney Dis., 30, S89, 1997.
84. Chatterjee, P. K. et al., Selective antagonism of the AT1 receptor inhibits angiotensin II stimulated DNA and protein synthesis in primary cultures of human proximal tubular cells, Kidney Int., 52, 699, 1997.
85. McDonald, M. C. et al., Effects of 5-aminoisoquinolinone, a water-soluble, potent inhibitor of the activity of poly(ADP-ribose) polymerase on the organ injury and dysfunction caused by hemorrhagic shock, Br. J. Pharmacol., 130, 843, 2000.
86. Smith, S., The world according to PARP, Trends Biochem. Sci., 26, 174, 2001.